Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Do corticosteroids prevent post-herpetic neuralgia?

K Keczkes, A M Basheer

    The British Journal of Dermatology
    |May 1, 1980
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Larva Migrans.

    Indian journal of dermatology, venereology and leprology·2017
    Same author

    Perforation of the Hard Palate Due to Tuberculosis.

    Indian journal of dermatology, venereology and leprology·2017
    Same author

    Evaluation of post-exposure vaccination against rabies in cattle.

    The new microbiologica·1997
    Same author

    Clinical, ultrasound and hormonal markers of androgenicity in acne vulgaris.

    The British journal of dermatology·1995
    Same author

    The emerging epidemic of skin cancer.

    The British journal of dermatology·1994
    Same author

    Extensive and fatal basal cell carcinoma: a report of three cases.

    The British journal of dermatology·1992

    Prednisolone significantly reduced the incidence and duration of post-herpetic neuralgia in patients over 50 with early, severe herpes zoster. This antiviral treatment offers a better outcome than carbamazepine for managing shingles complications.

    Area of Science:

    • Neurology
    • Infectious Diseases
    • Dermatology

    Background:

    • Herpes zoster (shingles) can cause severe pain and lead to debilitating post-herpetic neuralgia (PHN).
    • Early and effective treatment is crucial to prevent complications like PHN.

    Purpose of the Study:

    • To compare the efficacy of prednisolone versus carbamazepine in preventing and reducing the duration of post-herpetic neuralgia in patients over 50 with early, severe herpes zoster.

    Main Methods:

    • A randomized controlled trial involving 40 otherwise healthy patients over 50 years old with early, severe herpes zoster.
    • Twenty patients received oral prednisolone (40 mg daily, tapering over 4 weeks).
    • Twenty patients received oral carbamazepine (100 mg four times daily).

    Main Results:

    Related Experiment Videos

    • Only 15% (3/20) of prednisolone-treated patients developed PHN, lasting up to 6 months.
    • 65% (13/20) of carbamazepine-treated patients developed PHN, with some lasting up to 2 years.
    • Prednisolone treatment significantly reduced both the incidence and duration of PHN compared to carbamazepine.

    Conclusions:

    • Prednisolone is more effective than carbamazepine in preventing and shortening the duration of post-herpetic neuralgia in this patient population.
    • Early intervention with prednisolone may be a preferred strategy for managing severe herpes zoster and its sequelae.
    • Neither treatment resulted in disseminated zoster or other complications.